Brookwood Investment Group LLC bought a new stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,296 shares of the company's stock, valued at approximately $1,925,000.
Other hedge funds have also recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in Procter & Gamble by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 56,472,195 shares of the company's stock worth $9,457,000,000 after acquiring an additional 1,267,419 shares during the last quarter. Norges Bank purchased a new position in shares of Procter & Gamble in the 4th quarter worth about $5,244,463,000. Northern Trust Corp boosted its holdings in shares of Procter & Gamble by 10.1% in the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock worth $4,928,107,000 after purchasing an additional 2,703,757 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Procter & Gamble by 6.4% in the 4th quarter. Franklin Resources Inc. now owns 20,197,996 shares of the company's stock worth $3,386,194,000 after purchasing an additional 1,209,275 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, CEO Jennifer L. Davis sold 1,000 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the transaction, the chief executive officer directly owned 51,965 shares in the company, valued at $8,386,111.70. This trade represents a 1.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the firm's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider owned 25,182 shares in the company, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.18% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Piper Sandler increased their target price on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a report on Monday, May 5th. Barclays increased their target price on Procter & Gamble from $160.00 to $161.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday. UBS Group lowered their price target on Procter & Gamble from $186.00 to $180.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. Finally, Morgan Stanley set a $180.00 price target on Procter & Gamble and gave the company an "overweight" rating in a research report on Friday, April 25th. Nine analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $176.12.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Stock Down 0.3%
PG stock traded down $0.53 on Friday, reaching $158.28. 5,799,883 shares of the company traded hands, compared to its average volume of 9,070,670. Procter & Gamble Company has a one year low of $151.90 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50. The company has a market cap of $371.10 billion, a P/E ratio of 25.12, a price-to-earnings-growth ratio of 4.52 and a beta of 0.40. The firm has a fifty day simple moving average of $161.02 and a 200-day simple moving average of $164.22.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The business had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same period last year, the business posted $1.52 EPS. The company's revenue was down 2.1% compared to the same quarter last year. Research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.67%. Procter & Gamble's dividend payout ratio is 67.14%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report